.png)
Osteoarthritis Market by Diseases Type (Knee Osteoarthritis, Spine Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis and Hand Osteoarthritis), Treatment (Medication, Surgery, Therapy and Others), Diagnosis (Imaging, Joint fluid analysis and Others) and End-User (Hospital & clinics, Medical institute, Research organization and Others) - Global Industry Analysis & Forecast to 2027
Published On : August 2018 Pages : 185 Category: Biotechnology Report Code : HC081182
SEGMENTS & REGIONS:
- by Diseases Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis and Hand Osteoarthritis
- Treatment: Medication, Surgery, Therapy and Others
- Diagnosis: Imaging, Joint fluid analysis and Others
- User: Hospital & clinics, Medical institute, Research organization and Others
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
Osteoarthritis is one of the basis type of arthritis, it mainly affects the aged and overweight people. Osteoarthritis is also referred to as degenerative joint disease. Tissues (also known as cartilage) involved in the part where to bone end meet (joint), wear of and get damaged in Osteoarthritis. Knees, hands, spine and hips are the part mostly affected by Osteoarthritis. Rising number of aged people, growing predominance of osteoarthritis and grown expenditure on healthcare services by governments is the reason for booming of Acetic Anhydride Market. The National Institute of Health has predicted the growth in number of aged people in America twofold by 2050 compared to 2017.
Drivers and restrains
The main driving element of Osteoarthritis market is rise in number of aged population across the globe and increase in the obese population. Now-a-days change in lifestyle is one of the reasons for increase in Osteoarthritis disease. Joints are mostly affected it is due to lack of exercise which is also considered as one of the driving element for this market. Low annual income in growing economies and reactions due to the medical procedure involved the market growth can be limited in the predicted period.
Segmentation
The overall Osteoarthritis Market is divided depending on disease type, treatment, diagnosis and end-user. Division on the basis of Diseases Type; Knee Osteoarthritis, Shoulder Osteoarthritis Hand Osteoarthritis Spine Osteoarthritis Foot & Ankle Osteoarthritis. Division on basis of Treatment; Medication, Therapy, Surgery and Others. Division of the basis of Diagnosis; Joint fluid analysis, Imaging and Others. Division on basis of End-User: Medical institute, Research organization, Hospital & clinics and sothers.
Regional Outlook and Trend Analysis
Globally, American region is leading the osteoarthritis market due to large number of osteoarthritis affected people and the full-fledged medical service segment, also changing lifestyle and growth in investment on medical services. Next to America, Europe and Asia Pacific are the leading region in osteoarthritis market. Government’s investment in R&D sector, developed medical services, increased number of affected people, rise in expenditure on medical services are some of the factors predicting the growth of market. Developing countries such as India and China are seen to have a great chance for gaining the market in projected period. Africa has the slightest hold on osteoarthritis market due to poor economic development in some of the countries. Middle East has a large market share due to high budget assignment for medical service and due to advanced medical services available.
Competitive Insights
The approach of leading companies to get hold of the Osteoarthritis Market are; Regeneron, Abbott, Ampio Pharmaceuticals Inc., Novartis AG, Merck Sharp & Dohme Corp., Pfizer Inc. , Eli Lilly and Company., ABIOGEN PHARMA S.p.A, TissueGene Inc. and others.
The Osteoarthritis Market is segmented as follows-
By Diseases Type:
- Knee Osteoarthritis
- Spine Osteoarthritis
- Foot & Ankle Osteoarthritis
- Shoulder Osteoarthritis
- Hand Osteoarthritis
By Treatment:
- Medication
- Surgery
- Therapy
- Others
By Diagnosis:
- Imaging
- Joint fluid analysis
- Others
By End-User:
- Hospital & clinics
- Medical institute
- Research organization
- Others
Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Osteoarthritis Market, By Diseases Type, Estimates and Forecast, 2017-2027 ($Million)
o Knee Osteoarthritis
o Spine Osteoarthritis
o Foot & Ankle Osteoarthritis
o Shoulder Osteoarthritis
o Hand Osteoarthritis
· Osteoarthritis Market, By Treatment, Estimates and Forecast, 2017-2027 ($Million)
o Medication
o Surgery
o Therapy
o Others
· Osteoarthritis Market, By Diagnosis, Estimates and Forecast, 2017-2027 ($Million)
o Imaging
o Joint fluid analysis
o Others
· Osteoarthritis Market, End-User, Estimates and Forecast, 2017-2027 ($Million)
o Hospital & clinics
o Medical institute
o Research organization
o Others
· Osteoarthritis Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Osteoarthritis Market, By Country
o U.S. Osteoarthritis Market
o Canada Osteoarthritis Market
o Mexico Osteoarthritis Market
o Europe
§ Europe Osteoarthritis Market, By Country
o Germany Osteoarthritis Market
o UK Osteoarthritis Market
o France Osteoarthritis Market
o Russia Osteoarthritis Market
o Italy Osteoarthritis Market
o Rest of Europe Osteoarthritis Market
o Asia-Pacific
§ Asia-Pacific Osteoarthritis Market, By Country
o China Osteoarthritis Market
o Japan Osteoarthritis Market
o South Korea Osteoarthritis Market
o India Osteoarthritis Market
o Southeast Asia Osteoarthritis Market
o Rest of Asia-Pacific Osteoarthritis Market
o South America
§ South America Osteoarthritis Market
o Brazil Osteoarthritis Market
o Argentina Osteoarthritis Market
o Columbia Osteoarthritis Market
o Rest of South America Osteoarthritis Market
o Middle East and Africa
§ Middle East and Africa Osteoarthritis Market
o Saudi Arabia Osteoarthritis Market
o UAE Osteoarthritis Market
o Egypt Osteoarthritis Market
o Nigeria Osteoarthritis Market
o South Africa Osteoarthritis Market
o Rest of MEA Osteoarthritis Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Osteoarthritis Market, By Diseases Type
5.1. Introduction
5.2. Global Osteoarthritis Revenue and Market Share by Diseases Type (2017-2027)
5.2.1. Global Osteoarthritis Revenue and Revenue Share by Diseases Type (2017-2027)
5.3. Knee Osteoarthritis
5.3.1. Global Knee Osteoarthritis Revenue and Growth Rate (2017-2027)
5.4. Spine Osteoarthritis
5.4.1. Global Spine Osteoarthritis Revenue and Growth Rate (2017-2027)
5.5. Foot & Ankle Osteoarthritis
5.5.1. Global Foot & Ankle Osteoarthritis Revenue and Growth Rate (2017-2027)
5.6. Shoulder Osteoarthritis
5.6.1. Global Shoulder Osteoarthritis Revenue and Growth Rate (2017-2027)
5.7. Hand Osteoarthritis
5.7.1. Global Hand Osteoarthritis Revenue and Growth Rate (2017-2027)
6. Osteoarthritis Market, By Treatment
6.1. Introduction
6.2. Global Osteoarthritis Revenue and Market Share by Treatment (2017-2027)
6.2.1. Global Osteoarthritis Revenue and Revenue Share by Treatment (2017-2027)
6.3. Medication
6.3.1. Global Medication Revenue and Growth Rate (2017-2027)
6.4. Surgery
6.4.1. Global Surgery Revenue and Growth Rate (2017-2027)
6.5. Therapy
6.5.1. Global Therapy Revenue and Growth Rate (2017-2027)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2027)
7. Osteoarthritis Market, By Diagnosis
7.1. Introduction
7.2. Global Osteoarthritis Revenue and Market Share by Diagnosis (2017-2027)
7.2.1. Global Osteoarthritis Revenue and Revenue Share by Diagnosis (2017-2027)
7.3. Imaging
7.3.1. Global Imaging Revenue and Growth Rate (2017-2027)
7.4. Joint fluid analysis
7.4.1. Global Joint fluid analysis Revenue and Growth Rate (2017-2027)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2027)
8. Osteoarthritis Market, By End User
8.1. Introduction
8.2. Global Osteoarthritis Revenue and Market Share by End User (2017-2027)
8.2.1. Global Osteoarthritis Revenue and Revenue Share by End User (2017-2027)
8.3. Hospital & clinics
8.3.1. Global Hospital & clinics Revenue and Growth Rate (2017-2027)
8.4. Medical institute
8.4.1. Global Medical institute Revenue and Growth Rate (2017-2027)
8.5. Research organization
8.5.1. Global Research organization Revenue and Growth Rate (2017-2027)
8.6. Others
8.6.1. Global Others Revenue and Growth Rate (2017-2027)
9. Osteoarthritis Market, By Region
9.1. Introduction
9.2. Global Osteoarthritis Revenue and Market Share by Regions
9.2.1. Global Osteoarthritis Revenue by Regions (2017-2027)
9.3. North America Osteoarthritis by Countries
9.3.1. North America Osteoarthritis Revenue and Growth Rate (2017-2027)
9.3.2. North America Osteoarthritis Revenue (Million USD) by Countries (2017-2027)
9.3.3. United States
9.3.3.1. United States Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.4. Canada
9.3.4.1. Canada Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.5. Mexico
9.3.5.1. Mexico Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.4. Europe Osteoarthritis by Countries
9.4.1. Europe Osteoarthritis Revenue and Growth Rate (2017-2027)
9.4.2. Europe Osteoarthritis Revenue (Million USD) by Countries (2017-2027)
9.4.3. Germany
9.4.3.1. Germany Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.4. France
9.4.4.1. France Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.5. UK
9.4.5.1. UK Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.6. Russia
9.4.6.1. Russia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.7. Italy
9.4.7.1. Italy Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.8. Rest of Europe
9.4.8.1. Rest of Europe Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.5. Asia-Pacific Osteoarthritis by Countries
9.5.1. Asia-Pacific Osteoarthritis Revenue and Growth Rate (2017-2027)
9.5.2. Asia-Pacific Osteoarthritis Revenue (Million USD) by Countries (2017-2027)
9.5.3. China
9.5.3.1. China Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.4. Japan
9.5.4.1. Japan Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.5. Korea
9.5.5.1. Korea Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.6. India
9.5.6.1. India Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.7. Southeast Asia
9.5.7.1. Southeast Asia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.8. Rest of Asia-Pacific
9.5.8.1. Rest of Asia-Pacific Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.6. South America Osteoarthritis by Countries
9.6.1. South America Osteoarthritis Revenue and Growth Rate (2017-2027)
9.6.2. South America Osteoarthritis Revenue (Million USD) by Countries (2017-2027)
9.6.3. Brazil
9.6.3.1. Brazil Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.4. Argentina
9.6.4.1. Argentina Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.5. Columbia
9.6.5.1. Columbia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.6. Rest of South America
9.6.6.1. Rest of South America Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.7. Middle East and Africa Osteoarthritis by Countries
9.7.1. Middle East and Africa Osteoarthritis Revenue and Growth Rate (2017-2027)
9.7.2. Middle East and Africa Osteoarthritis Revenue (Million USD) by Countries (2017-2027)
9.7.3. Saudi Arabia
9.7.3.1. Saudi Arabia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.4. United Arab Emirates
9.7.4.1. United Arab Emirates Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.5. Egypt
9.7.5.1. Egypt Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.6. Nigeria
9.7.6.1. Nigeria Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.7. South Africa
9.7.7.1. South Africa Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.8. Turkey
9.7.8.1. Turkey Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.9. Rest of Middle East and Africa
9.7.9.1. Rest of Middle East and Africa Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
10. Company Profiles
10.1. Regeneron
10.1.1. Business Overview
10.1.2. Service Portfolio
10.1.3. Strategic Developments
10.1.4. Financial Overview
10.2. Abbott
10.2.1. Business Overview
10.2.2. Service Portfolio
10.2.3. Strategic Developments
10.2.4. Financial Overview
10.3. Ampio Pharmaceuticals Inc.
10.3.1. Business Overview
10.3.2. Service Portfolio
10.3.3. Strategic Developments
10.3.4. Financial Overview
10.4. Novartis AG
10.4.1. Business Overview
10.4.2. Service Portfolio
10.4.3. Strategic Developments
10.4.4. Financial Overview
10.5. Merck Sharp & Dohme Corp.
10.5.1. Business Overview
10.5.2. Service Portfolio
10.5.3. Strategic Developments
10.5.4. Financial Overview
10.6. Pfizer Inc.
10.6.1. Business Overview
10.6.2. Service Portfolio
10.6.3. Strategic Developments
10.6.4. Financial Overview
10.7. Eli Lilly and Company.
10.7.1. Business Overview
10.7.2. Service Portfolio
10.7.3. Strategic Developments
10.7.4. Financial Overview
10.8. ABIOGEN PHARMA S.p.A
10.8.1. Business Overview
10.8.2. Service Portfolio
10.8.3. Strategic Developments
10.8.4. Financial Overview
10.9. TissueGene Inc.
10.9.1. Business Overview
10.9.2. Service Portfolio
10.9.3. Strategic Developments
10.9.4. Financial Overview
11. Osteoarthritis Market Forecast (2017-2027)
11.1. Global Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Osteoarthritis Market Forecast by Regions (2017-2027)
11.2.1. North America Osteoarthritis Market Forecast (2017-2027)
11.2.1.1. United States Osteoarthritis Market Forecast (2017-2027)
11.2.1.2. Canada Osteoarthritis Market Forecast (2017-2027)
11.2.1.3. Mexico Osteoarthritis Market Forecast (2017-2027)
11.2.2. Europe Osteoarthritis Market Forecast (2017-2027)
11.2.2.1. Germany Osteoarthritis Market Forecast (2017-2027)
11.2.2.2. France Osteoarthritis Market Forecast (2017-2027)
11.2.2.3. UK Osteoarthritis Market Forecast (2017-2027)
11.2.2.4. Russia Osteoarthritis Market Forecast (2017-2027)
11.2.2.5. Italy Osteoarthritis Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Osteoarthritis Market Forecast (2017-2027)
11.2.3. Asia-Pacific Osteoarthritis Market Forecast (2017-2027)
11.2.3.1. China Osteoarthritis Market Forecast (2017-2027)
11.2.3.2. Japan Osteoarthritis Market Forecast (2017-2027)
11.2.3.3. Korea Osteoarthritis Market Forecast (2017-2027)
11.2.3.4. India Osteoarthritis Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Osteoarthritis Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Osteoarthritis Market Forecast (2017-2027)
11.2.4. South America Osteoarthritis Market Forecast (2017-2027)
11.2.4.1. Brazil Osteoarthritis Market Forecast (2017-2027)
11.2.4.2. Argentina Osteoarthritis Market Forecast (2017-2027)
11.2.4.3. Columbia Osteoarthritis Market Forecast (2017-2027)
11.2.4.4. Rest of South America Osteoarthritis Market Forecast (2017-2027)
11.2.5. Middle East and Africa Osteoarthritis Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Osteoarthritis Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Osteoarthritis Market Forecast (2017-2027)
11.2.5.3. Egypt Osteoarthritis Market Forecast (2017-2027)
11.2.5.4. Nigeria Osteoarthritis Market Forecast (2017-2027)
11.2.5.5. South Africa Osteoarthritis Market Forecast (2017-2027)
11.2.5.6. Turkey Osteoarthritis Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Osteoarthritis Market Forecast (2017-2027)
11.3. Osteoarthritis Market Forecast by Diseases Type (2017-2027)
11.3.1. Osteoarthritis Forecast by Diseases Type (2017-2027)
11.3.2. Osteoarthritis Market Share Forecast by Diseases Type (2017-2027)
11.4. Osteoarthritis Market Forecast by Treatment (2017-2027)
11.4.1. Osteoarthritis Forecast by Treatment (2017-2027)
11.4.2. Osteoarthritis Market Share Forecast by Treatment (2017-2027)
11.5. Osteoarthritis Market Forecast by Diagnosis (2017-2027)
11.5.1. Osteoarthritis Forecast by Diagnosis (2017-2027)
11.5.2. Osteoarthritis Market Share Forecast by Diagnosis (2017-2027)
11.6. Osteoarthritis Market Forecast by End User (2017-2027)
11.6.1. Osteoarthritis Forecast by End User (2017-2027)
11.6.2. Osteoarthritis Market Share Forecast by End User (2017-2027)
List of Tables
Figure United States Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Osteoarthritis Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Osteoarthritis Revenue and Revenue Share by Diseases Type (2017-2018)
Figure Global Knee Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure Global Spine Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure Global Foot & Ankle Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure Global Shoulder Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure Global Hand Osteoarthritis Revenue and Growth Rate (2017-2018)
Table Global Osteoarthritis Revenue and Revenue Share by Treatment (2017-2018)
Figure Global Medication Revenue and Growth Rate (2017-2018)
Figure Global Surgery Revenue and Growth Rate (2017-2018)
Figure Global Therapy Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Osteoarthritis Revenue and Revenue Share by Diagnosis (2017-2018)
Figure Global Imaging Revenue and Growth Rate (2017-2018)
Figure Global Joint fluid analysis Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Osteoarthritis Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospital & clinics Revenue and Growth Rate (2017-2018)
Figure Global Medical institute Revenue and Growth Rate (2017-2018)
Figure Global Research organization Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Osteoarthritis Revenue by Regions (2017-2018)
Figure North America Osteoarthritis Growth Rate (2017-2018)
Figure North America Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure North America Osteoarthritis by Countries (2017-2018)
Figure North America Osteoarthritis Revenue (Million USD) by Countries (2017-2018)
Figure United States Osteoarthritis Growth Rate (2017-2018)
Figure United States Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Osteoarthritis Growth Rate (2017-2018)
Figure Canada Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Osteoarthritis Growth Rate (2017-2018)
Figure Mexico Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Osteoarthritis Growth Rate (2017-2018)
Figure Europe Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure Europe Osteoarthritis by Countries (2017-2018)
Figure Europe Osteoarthritis Revenue (Million USD) by Countries (2017-2018)
Figure Germany Osteoarthritis Growth Rate (2017-2018)
Figure Germany Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Osteoarthritis Growth Rate (2017-2018)
Figure France Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Osteoarthritis Growth Rate (2017-2018)
Figure UK Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Osteoarthritis Growth Rate (2017-2018)
Figure Russia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Osteoarthritis Growth Rate (2017-2018)
Figure Italy Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Osteoarthritis Growth Rate (2017-2018)
Figure Rest of Europe Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Osteoarthritis Growth Rate (2017-2018)
Figure Asia-Pacific Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Osteoarthritis by Countries (2017-2018)
Figure Asia-Pacific Osteoarthritis Revenue (Million USD) by Countries (2017-2018)
Figure China Osteoarthritis Growth Rate (2017-2018)
Figure China Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Osteoarthritis Growth Rate (2017-2018)
Figure Japan Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Osteoarthritis Growth Rate (2017-2018)
Figure Korea Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Osteoarthritis Growth Rate (2017-2018)
Figure India Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Osteoarthritis Growth Rate (2017-2018)
Figure Southeast Asia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Osteoarthritis Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Osteoarthritis Growth Rate (2017-2018)
Figure South America Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure South America Osteoarthritis by Countries (2017-2018)
Figure South America Osteoarthritis Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Osteoarthritis Growth Rate (2017-2018)
Figure Brazil Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Osteoarthritis Growth Rate (2017-2018)
Figure Argentina Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Osteoarthritis Growth Rate (2017-2018)
Figure Columbia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Osteoarthritis Growth Rate (2017-2018)
Figure Rest of South America Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Osteoarthritis Growth Rate (2017-2018)
Figure Middle East and Africa Osteoarthritis Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Osteoarthritis by Countries (2017-2018)
Figure Middle East and Africa Osteoarthritis Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Osteoarthritis Growth Rate (2017-2018)
Figure Saudi Arabia Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Osteoarthritis Growth Rate (2017-2018)
Figure United Arab Emirates Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Osteoarthritis Growth Rate (2017-2018)
Figure Egypt Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Osteoarthritis Growth Rate (2017-2018)
Figure Nigeria Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Osteoarthritis Growth Rate (2017-2018)
Figure South Africa Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Osteoarthritis Growth Rate (2017-2018)
Figure Turkey Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Osteoarthritis Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Osteoarthritis Revenue (Millions USD) and Growth Rate (2017-2018)
Table Regeneron Osteoarthritis Financial Overview
Table Abbott Osteoarthritis Financial Overview
Table Ampio Pharmaceuticals Inc. Osteoarthritis Financial Overview
Table Novartis AG Osteoarthritis Financial Overview
Table Merck Sharp & Dohme Corp. Osteoarthritis Financial Overview
Table Pfizer Inc. Osteoarthritis Financial Overview
Table Eli Lilly and Company. Osteoarthritis Financial Overview
Table ABIOGEN PHARMA S.p.A Osteoarthritis Financial Overview
Table TissueGene Inc. Osteoarthritis Financial Overview
Figure Global Osteoarthritis Revenue (Millions USD) and Growth Rate (2018-2025)
Table Osteoarthritis Market Forecast by Regions (2018-2025)
Figure North America Osteoarthritis Market Forecast (2018-2025)
Figure United States Osteoarthritis Market Forecast (2018-2025)
Figure Canada Osteoarthritis Market Forecast (2018-2025)
Figure Mexico Osteoarthritis Market Forecast (2018-2025)
Figure Europe Osteoarthritis Market Forecast (2018-2025)
Figure Germany Osteoarthritis Market Forecast (2018-2025)
Figure France Osteoarthritis Market Forecast (2018-2025)
Figure UK Osteoarthritis Market Forecast (2018-2025)
Figure Russia Osteoarthritis Market Forecast (2018-2025)
Figure Italy Osteoarthritis Market Forecast (2018-2025)
Figure Rest of Europe Osteoarthritis Market Forecast (2018-2025)
Figure Asia-Pacific Osteoarthritis Market Forecast (2018-2025)
Figure China Osteoarthritis Market Forecast (2018-2025)
Figure Japan Osteoarthritis Market Forecast (2018-2025)
Figure Korea Osteoarthritis Market Forecast (2018-2025)
Figure India Osteoarthritis Market Forecast (2018-2025)
Figure Southeast Asia Osteoarthritis Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Osteoarthritis Market Forecast (2018-2025)
Figure South America Osteoarthritis Market Forecast (2018-2025)
Figure Brazil Osteoarthritis Market Forecast (2018-2025)
Figure Argentina Osteoarthritis Market Forecast (2018-2025)
Figure Columbia Osteoarthritis Market Forecast (2018-2025)
Figure Rest of South America Osteoarthritis Market Forecast (2018-2025)
Figure Middle East and Africa Osteoarthritis Market Forecast (2018-2025)
Figure Saudi Arabia Osteoarthritis Market Forecast (2018-2025)
Figure United Arab Emirates Osteoarthritis Market Forecast (2018-2025)
Figure Egypt Osteoarthritis Market Forecast (2018-2025)
Figure Nigeria Osteoarthritis Market Forecast (2018-2025)
Figure South Africa Osteoarthritis Market Forecast (2018-2025)
Figure Turkey Osteoarthritis Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Osteoarthritis Market Forecast (2018-2025)
Figure Global Osteoarthritis Forecast by Diseases Type (2018-2025)
Figure Global Osteoarthritis Market Share Forecast by Diseases Type (2018-2025)
Figure Global Osteoarthritis Forecast by Diseases Type (2018-2025)
Figure Global Osteoarthritis Forecast by Treatment (2018-2025)
Figure Global Osteoarthritis Market Share Forecast by Treatment (2018-2025)
Figure Global Osteoarthritis Forecast by Treatment (2018-2025)
Figure Global Osteoarthritis Forecast by Diagnosis (2018-2025)
Figure Global Osteoarthritis Market Share Forecast by Diagnosis (2018-2025)
Figure Global Osteoarthritis Forecast by Diagnosis (2018-2025)
Figure Global Osteoarthritis Forecast by End User (2018-2025)
Figure Global Osteoarthritis Market Share Forecast by End User (2018-2025)
Figure Global Osteoarthritis Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|